During 10 years of follow‐up after surgical resection of colorectal tumours, only patients with medium or high TGFβ expression in the primary tumour suffered cancer recurrence, whereas all patients bearing TGFβ ‐low stage I, II and III tumours remained disease‐free 94. This evidence concerns the gene TGFB1 and neoplasm.